Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, "Orchestra BioMed" or the "Company"), a biomedical innovation company accelerating high-impact technologies ...
Read the Market Summary Here @- Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Booming at Healthy CAGR of 8.4% to Touch USD 11.6 Billion by 2030 Global Cardiac Resynchronization ...
NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact ...
KMC Hospital in Mangaluru successfully treats Rev Fr Wolfgang Leonhard, a German priest, diagnosed with hypertrophic obstructive cardiomyopathy and complete heart block. The cardiology team implanted ...
In a remarkable display of expertise and advanced cardiac care, KMC Hospital, Dr B R Ambedkar Circle successfully treated Fr Wolfgang Leonhard, a 65-year-old German national, who was rushed to the ...
Half of all pacemakers implanted in the United States are for patients aged 75 years and older. The expectations and needs of an older group are different from patients who are younger, yet it is ...
Ilyas Khan, who is also a interventional cardiologist at the Heart Institute. AVEIR DR, developed by Abbott, is the world’s first dual chamber leadless pacemaker system designed to effectively treat ...
Ongoing strategic agreements, acquisitions and new product launches will further assist key companies in strengthening their global market presence. Cardiac Pacemaker Industry News Dual-chamber ...
(Update: Medtronic announced FDA approval for its Affera cardiac mapping and ablation system with the Sphere-9 catheter in October 2024.) Medtronic acquired the Sphere-9 catheter for pulsed field ...